We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Register to vote Register by 18 June to vote in the General Election on 4 July.
The study shows partial antiviral activity of maraviroc (MVC) when tested in multiple preclinical dosing strategies
MHRA review of levothyroxine products in response to concerns about potential inconsistencies of different products.
Tillomed Laboratories Limited is recalling one batch of Labetalol 200mg Tablets due to an error on the foil blister packaging.
A summary of recent letters and notifications sent to healthcare professionals about medicines and medical devices.
Information for healthcare professionals on the clinical investigation and management of COVID-19 vaccine induced thrombosis and thrombocytopenia (VITT).
Dapivirine (DPV) and maraviroc (MVC) were formulated into aqueous gels designed to prevent mucosal HIV transmission
Change to the information provided on adverse events in the Summary of Product Characteristics (SPC).
Systematic reviews and meta-analyses of randomised controlled trials have highlighted a dose-dependent increased risk of atrial fibrillation in patients with established cardiovascular diseases or cardiovascular risk factors treated with omega-3-acid ethyl ester medicines compared to placebo.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).